Fortress Biotech, Inc. Gain (Loss) on Disposition of Assets
Fortress Biotech, Inc. (FBIO) reported Gain (Loss) on Disposition of Assets of $0 for the 12-month period ending 2020-12-31, per its 10-K/A filed 2021-04-09.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2021-04-09
- Fortress Biotech, Inc. gain (loss) on disposition of assets for the quarter ending 2020-12-31 was $0.00.
- Fortress Biotech, Inc. gain (loss) on disposition of assets for the quarter ending 2020-09-30 was $0.00.
- Fortress Biotech, Inc. gain (loss) on disposition of assets for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- Fortress Biotech, Inc. gain (loss) on disposition of assets for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- Fortress Biotech, Inc. gain (loss) on disposition of assets for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- Fortress Biotech, Inc. gain (loss) on disposition of assets for fiscal 2019 was $18.48M.
- Fortress Biotech, Inc. gain (loss) on disposition of assets for fiscal 2018 was $0.00.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-09 | $0.00 derived: sum of 2 quarters · filed 2021-04-09 | $0.00 derived: sum of 3 quarters · filed 2021-04-09 | $0.00 10-K/A · filed 2021-04-09 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-04-09 | $0.00 10-Q · filed 2020-11-09 | -$45.00K derived: sum of 4 quarters · filed 2021-04-09 |
| 2020-06-30 | $0.00 derived: 10-K/A 12 month − 3 quarters · filed 2021-04-09 | $0.00 derived: sum of 2 quarters · filed 2021-04-09 | -$45.00K derived: sum of 3 quarters · filed 2021-04-09 | -$45.00K derived: sum of 4 quarters · filed 2021-04-09 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-11 | -$45.00K derived: sum of 2 quarters · filed 2021-04-09 | -$45.00K derived: sum of 3 quarters · filed 2021-04-09 | $92.00K derived: sum of 4 quarters · filed 2021-04-09 |
| 2019-12-31 | -$45.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-09 | -$45.00K derived: sum of 2 quarters · filed 2021-04-09 | $92.00K derived: sum of 3 quarters · filed 2021-04-09 | $18.48M 10-K/A · filed 2021-04-09 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-09 | $137.00K derived: sum of 2 quarters · filed 2020-11-09 | $18.52M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $137.00K 10-Q · filed 2020-08-10 | $18.52M 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $18.38M 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-03-16 | |||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |